Ryoncil

remestemcel-L-rknd

Approval

ApplicationBLA 125706
Approval dateDec 19, 2024
Approval year2024
SponsorMesoblast, Inc

FDA-approved use

the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months of age and older

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Ryoncil: